NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Amplifold

Amplifold

Private
GermanyHealthcare & Life Scienceshttps://amplifold.com/

Last Round

Seed

Dec 10, 2025

Total Funding Raised

$5.82M

Momentum

Top 5%

of companies Caplight tracks

Company Overview

Amplifold is a biotechnology company that develops a DNA-origami-based signal amplification platform to enhance the sensitivity of lateral flow assays.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Medical Devices, Biotech Equipment

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Non-AI

Keywords

molecular diagnosticsin vitro diagnosticsIVDDNA origamisignal amplificationdiagnostic hardwareassay reagentslateral flowbiotech platformclinical testingnanotechnologydiagnostic techlab techbiotech R&Ddeep tech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Amplifold Comps

Public and private peers based on sector, stage, and business model.

Amplifold comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Amplifold Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedDec 10, 2025

Amplifold Investors

Notable investors and investment history

Amplifold investors
InvestorRounds
xista science venturesSeed
Matterwave VenturesSeed
b2ventureSeed
Becker VenturesSeed
Bayern KapitalSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 1, 2026

    Dr Federico Bürsgens to join as CEO, effective July 1st, 2026.

  • Jan 10, 2026

    Grew 200% QoQ, from 3 to 9 employees.

Amplifold Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Amplifold Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Amplifold's valuation, stock price, and market status.

Firmographic Details

HeadquartersGermany
Employee Range12
Year Founded2025
Last FundingDec 10, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.